The working-capital provider has raised a two-year credit facility to support growing e-commerce brands.
"Scaling responsibly alongside leading global financial institutions enhances our ability to provide fast, flexible capital to more founders, helping businesses invest in growth and navigate volatility with greater confidence,"
ARCH Venture Partners led the oversubscribed round alongside participation from +ND Capital, OMX Ventures, and Meltwind.
"Syndex Bio’s mcPCR platform makes amplifying DNA methylation possible for the first time. This powerful method will redefine the sensitivity and accuracy that is achievable in DNA methylation analysis, opening new possibilities for early detection and disease monitoring."
The funding round was led by SFC Capital to support expansion into NHS England trusts.
"Pontiro was built inside the NHS, alongside the teams who use it every day. That matters. With this investment, we’re taking infrastructure that already works at scale in Wales and making it available to trusts across the country who are navigating the same challenges."
The funding combines angel investment with Innovate UK support to advance medical technology development.
"Taking part in the Elevate Her Accelerator was a turning point for ClotProtect. The support, mentorship and belief from the Lifted team, particularly from Jordan, has been instrumental in helping us secure Innovate UK funding and close this £1.2 million round. This investment gives us the platform to scale faster and bring our technology to more patients who need it."